140 related articles for article (PubMed ID: 15089761)
1. The predictive value of megakaryocytic and erythroid colony formation and platelet function tests on the risk of thromboembolic and bleeding complications in essential thrombocythaemia.
Niittyvuopio R; Juvonen E; Kekomäki R; Oksanen K; Anttila P; Ruutu T
Eur J Haematol; 2004 Apr; 72(4):245-51. PubMed ID: 15089761
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and diagnostic value of endogenous erythroid colony formation in essential thrombocythemia.
Ciaudo M; Hadjez JM; Teyssandier I; Coly E; Zittoun R; Marie JP
Hematol Cell Ther; 1998 Aug; 40(4):171-4. PubMed ID: 9766922
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
[TBL] [Abstract][Full Text] [Related]
4. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.
Florensa L; Besses C; Woessner S; Solé F; Acín P; Pedro C; Sans-Sabrafen J
Leukemia; 1995 Feb; 9(2):271-3. PubMed ID: 7869763
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
6. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.
Vannucchi AM; Grossi A; Pancrazzi A; Antonioli E; Guglielmelli P; Balestri F; Biscardi M; Bulgarelli S; Longo G; Graziano C; Gugliotta L; Bosi A
Br J Haematol; 2004 Oct; 127(2):214-9. PubMed ID: 15461629
[TBL] [Abstract][Full Text] [Related]
7. A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia.
Dobo I; Boiret N; Lippert E; Girodon F; Mossuz P; Donnard M; Campos L; Pineau D; Bascans E; Praloran V; Hermouet S
Haematologica; 2004 Oct; 89(10):1207-12. PubMed ID: 15477205
[TBL] [Abstract][Full Text] [Related]
8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
Petrides PE; Siegel F
Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous megakaryocytic colony formation does not discriminate between essential thrombocythemia and polycythemia vera.
Escoffre-Barbe M; Amiot L; Beaucournu P; Jego P; Grulois I; Grosbois B; Bernard M; Fest T; Lamy T; Fardel O
Am J Hematol; 2006 Jul; 81(7):554-6. PubMed ID: 16755572
[TBL] [Abstract][Full Text] [Related]
11. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications.
Juvonen E; Ikkala E; Oksanen K; Ruutu T
Br J Haematol; 1993 Feb; 83(2):192-7. PubMed ID: 8457466
[TBL] [Abstract][Full Text] [Related]
12. Colony formation by megakaryocytic progenitors in essential thrombocythaemia.
Juvonen E; Partanen S; Ruutu T
Br J Haematol; 1987 Jun; 66(2):161-4. PubMed ID: 3606955
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic and thrombotic complications in polycythemia vera. A clinical study.
Orlandi E; Castelli G; Brusamolino E; Canevari A; Morra E; Lazzarino M; Bernasconi C
Haematologica; 1989; 74(1):45-9. PubMed ID: 2498182
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.
Pelicano N; Branco LM; Pinto A; Sá A; Timóteo AT; Feliciano J; Fiarresga A; Agapito AF; Palma MC; Quininha J
Rev Port Cardiol; 2005; 24(7-8):957-68. PubMed ID: 16240682
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.
Cortelazzo S; Finazzi G; Ruggeri M; Vestri O; Galli M; Rodeghiero F; Barbui T
N Engl J Med; 1995 Apr; 332(17):1132-6. PubMed ID: 7700286
[TBL] [Abstract][Full Text] [Related]
16. [Essential thrombocythemia: antiaggregants].
Cortelazzo S; Barbui T
Haematologica; 1991 Jun; 76 Suppl 3():371-3. PubMed ID: 1752535
[No Abstract] [Full Text] [Related]
17. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
18. Significantly reduced spontaneous thrombolytic activity in older men: a possible explanation for the gender differences in risk of acute coronary syndromes.
Yamashita T; Sato A; Ikarugi H; Inoue A; Kitamori K; Ishii H; Yamamoto J
Thromb Res; 2005; 116(2):127-31. PubMed ID: 15907527
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of platelet function using stagnation point flow aggregometry. First clinical results.
Reininger CB; Reininger AJ; Hörmann A; Steckmeier B; Schweiberer L
Int Angiol; 1992; 11(4):247-55. PubMed ID: 1295930
[TBL] [Abstract][Full Text] [Related]
20. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
